Comments

Verona Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Verona Pharma (VRNA) operate in?

Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VRNANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$74.09

At close: May 21 EDT

$74.09

0.000.00%

Pre-Market: 4:00 PM EDT

Verona Pharma (VRNA) Forecast

News Earnings Verona Pharma (VRNA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Verona Pharma Stock Price, Quotes and Forecasts | NASDAQ:VRNA | Benzinga

Explore Verona Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRNA.

Open	-
Close	-
Volume / Avg.	42.00 / 1.45M
Day Range	- - -
52 Wk Range	11.39 - 75.60
Market Cap	$6.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	9.81%
Days to Cover	5.02

Recent News

Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug

GSK's Phase 3 MATINEE trial of Nucala in COPD met the primary endpoint, reducing exacerbations significantly over 104 weeks.

Vandana Singh

Top 3 Health Care Stocks That May Crash In August

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	42.00 / 1.45M
Day Range	- - -
52 Wk Range	11.39 - 75.60
Market Cap	$6.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	9.81%
Days to Cover	5.02

About Verona Pharma Plc

Sector

Health Care

Industry

Pharmaceuticals

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercial...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verona Pharma (VRNA) stock?

You can purchase shares of Verona Pharma (NASDAQ:VRNA) through any online brokerage.

View our list of the best stock brokerages

Who are Verona Pharma (VRNA) competitors?

Other companies in Verona Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Haleon (NYSE:HLN).

What is the forecast, or price target, for Verona Pharma (VRNA) stock?

Verona Pharma has a consensus price target of $61.13.

What is the current price for Verona Pharma (VRNA)?

The stock price for Verona Pharma (NASDAQ: VRNA) is $74.09 last updated May 21, 2025 at 4:00 PM EDT.

Does Verona Pharma (VRNA) pay a dividend?

There are no upcoming dividends for Verona Pharma.

When is Verona Pharma (NASDAQ:VRNA) reporting earnings?

Verona Pharma’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Verona Pharma (VRNA) going to split?

There is no upcoming split for Verona Pharma.

What sector and industry does Verona Pharma (VRNA) operate in?

Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.